ArticleCancer letters2025

Corrigendum to "Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer" [604 (2024) 217219 1-12].

María Rosario Chica-Parrado et al.PubMed ↗Publisher ↗

No numbers read from the abstract.